Cargando…

The impact of “4 + 7” volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis

BACKGROUND: In 2019, Chinese government launched a nationwide volume-based drug procurement aiming at reducing drug prices and saving drug costs through economies of scale, which aroused widespread attention. The first round of the policy pilot was implemented in 4 municipalities and 7 sub-provincia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ying, Tong, Ruiwen, Yin, Shicheng, Mao, Lining, Xu, Luxinyi, Hao, Siyu, Mao, Zongfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620621/ https://www.ncbi.nlm.nih.gov/pubmed/34823516 http://dx.doi.org/10.1186/s12913-021-07143-3

Ejemplares similares

The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China
por: Chen, Lei, et al.
Publicado: (2020)

The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018–2019: an interrupted time-series analysis
por: Yang, Ying, et al.
Publicado: (2021)

Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
por: Wang, Ni, et al.
Publicado: (2021)

Impact of ‘4+7’ volume-based drug procurement on the use of policy-related original and generic drugs: a natural experimental study in China
por: Wang, Jing, et al.
Publicado: (2022)

The Effects of the National Centralized Drug Purchasing Pilot Program on Nucleos(t)ide Analogs in Shenzhen City: An Interrupted Time Series Analysis
por: Wen, Xiaotong, et al.
Publicado: (2021)

A quasi-experimental study of the volume-based procurement (VBP) effect on antiviral medications of hepatitis B virus in China
por: Wen, Xiaotong, et al.
Publicado: (2023)

The impacts of the “4+7” pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study
por: Wen, Xiaotong, et al.
Publicado: (2022)

Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls
por: Chen, Yilin, et al.
Publicado: (2021)

The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis
por: Wang, Xiao, et al.
Publicado: (2023)

Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series
por: Long, Hongfei, et al.
Publicado: (2022)

Effects of volume-based procurement policy on the usage and expenditure of first-generation targeted drugs for non-small cell lung cancer with EGFR mutation in China: an interrupted time series study
por: Wang, Xiaoyang, et al.
Publicado: (2023)

Impacts of National Drug Price Negotiation on Expenditure, Volume, and Availability of Targeted Anti-Cancer Drugs in China: An Interrupted Time Series Analysis
por: Sun, Yan, et al.
Publicado: (2022)

Reevaluation of adverse drug reactions of psychiatric drugs under the chinese drug volume-based procurement policy
por: Du, Zhiqiang, et al.
Publicado: (2022)

Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus
por: Yuan, Jing, et al.
Publicado: (2022)

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
por: Huang, Tao, et al.
Publicado: (2021)

Impacts of adjustment of National Reimbursement Drug List on orphan drugs volume and spending in China: an interrupted time series analysis
por: Yi, Hongbin, et al.
Publicado: (2023)

The change of drug utilization in China’s public healthcare institutions under the “4 + 7” centralized drug procurement policy: Evidence from a natural experiment in China
por: Lu, Jiancheng, et al.
Publicado: (2022)

Effects of drug price reduction and prescribing restrictions on expenditures and utilisation of antihypertensive drugs in Korea
por: Yoo, Ki-Bong, et al.
Publicado: (2015)

Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China
por: Yuan, Jing, et al.
Publicado: (2021)

Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China
por: Zhao, Xinyu, et al.
Publicado: (2022)

Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis
por: Mathieu, Clément, et al.
Publicado: (2023)

Patients' attitudes towards switching to national volume-based procurement (NVBP) Drugs—a qualitative investigation in Wuhan, China
por: Tao, Jinyi, et al.
Publicado: (2023)

The Impact of Prescribing Monitoring Policy on Drug Use and Expenditures in China: A Multi-center Interrupted Time Series Study
por: Nie, Xiaoyan, et al.
Publicado: (2023)

Impact of the zero-mark-up drug policy on drug-related expenditures and use in public hospitals, 2016–2018: an interrupted time series study in Shaanxi
por: Yan, Kangkang, et al.
Publicado: (2020)

Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004–2011
por: Luo, Jing, et al.
Publicado: (2014)

Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
por: Zhu, Yahui, et al.
Publicado: (2023)

Impacts of a New Episode-Based Payment Scheme on Volume, Expenditures, and Efficiency in Public Hospitals: A Quasi-Experimental Interrupted Time-Series Study in Jinhua, China
por: Zhang, Tao, et al.
Publicado: (2022)

Improving access to medicines and beyond: the national volume-based procurement policy in China
por: Zhu, Zheng, et al.
Publicado: (2023)

Association of flavoured cigar regulations with wholesale tobacco volumes in Canada: an interrupted time series analysis
por: Chaiton, Michael O, et al.
Publicado: (2019)

Does China improve social welfare after implementing the national volume-based procurement?
por: Wang, Huan, et al.
Publicado: (2023)

Energy expenditure of interruptions to sedentary behavior
por: Swartz, Ann M, et al.
Publicado: (2011)

Effects of prescription restrictive interventions on antibiotic procurement in primary care settings: a controlled interrupted time series study in China
por: Tang, Yuqing, et al.
Publicado: (2018)

Impact of the economic crisis on household health expenditure in Greece: an interrupted time series analysis
por: Crookes, Catriona, et al.
Publicado: (2020)

Individualization of Antihypertensive Drug Treatment
por: Mancia, Giuseppe, et al.
Publicado: (2013)

Sympathetic modulation by antihypertensive drugs
por: Katsurada, Kenichi, et al.
Publicado: (2021)

Antibiotic Use in China’s Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018–2020
por: Yang, Ying, et al.
Publicado: (2022)

Drug procurement, the Global Fund and misguided competition policies
por: Tren, Richard, et al.
Publicado: (2009)

Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis
por: Morrow, Richard L, et al.
Publicado: (2022)

Volume of Distribution is Unaffected by Metabolic Drug–Drug Interactions
por: Sodhi, Jasleen K., et al.
Publicado: (2020)

The Effects of a New Public Medicine Procurement Policy on Medicine Price in Shaanxi Province, Western China: An Interrupted Time Series Analysis
por: Hu, Shuchen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9t24eo115cqsb5iooen7uu28hj